Finance

Lists
Why is 3696 up ३.८८%?
Dive Deeper
3696:HKG
Insilico Medicine Cayman TopCo
HK$ ३९.१०
+३.८८%
(+१.४६) 1D
अक्टोबर १६, १६:०८:१४ GMT+८  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 3696...
Open
HK$ ३९.१६
High
HK$ ४०.२८
Low
HK$ ३८.१२
Mkt. cap
२२.८८ अरब
Avg. vol.
१.५७ करोड
Volume
१.५७ करोड
52-wk high
HK$ ८०.९०
52-wk low
HK$ २९.९८
EPS
-HK$ ४.२०
Shares outstanding
५५.७४ करोड
No. of employees
३३३
Open
HK$ ३९.१६
High
HK$ ४०.२८
Low
HK$ ३८.१२
Mkt. cap
२२.८८ अरब
Avg. vol.
१.५७ करोड
Volume
१.५७ करोड
52-wk high
HK$ ८०.९०
52-wk low
HK$ २९.९८
EPS
-HK$ ४.२०
Shares outstanding
५५.७४ करोड
No. of employees
३३३
News stories
From web sources and news partners
Profile
Insilico Medicine is a biotechnology company headquartered in Boston, Massachusetts, with additional facilities in Pak Shek Kok, Hong Kong in Hong Kong Science Park near the Chinese University of Hong Kong, and in New York, at The Cure by Deerfield. The company applies genomics, big data analysis, and deep learning for in silico drug discovery. Wikipedia
About Insilico Medicine Cayman TopCo
CEOFeng Ren | Alex Zhavoronkov
Employees३३३
Founded२०१४
Headquarters-
Sector-
Last report
२०२६ अगस्ट २६
Fiscal period
Q2 2026
- / -
Revenue / Est. (USD)
५.३२ करोड / -
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
१.४४ करोड
१.४४ करोड
५.३२ करोड
५.३२ करोड
Cost of goods sold
२९.७७ लाख
२९.७७ लाख
५१.६९ लाख
५१.६९ लाख
Cost of revenue
२९.७७ लाख
२९.७७ लाख
५१.६९ लाख
५१.६९ लाख
Research and development expenses
२.२९ करोड
२.२९ करोड
२.४७ करोड
२.४७ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
७०.५२ लाख
७०.५२ लाख
९४.७१ लाख
९४.७१ लाख
Operating expense
३.०२ करोड
३.०२ करोड
३.३८ करोड
३.३८ करोड
Total operating expenses
३.३२ करोड
३.३२ करोड
३.९० करोड
३.९० करोड
Operating income
-१.८८ करोड
-१.८८ करोड
१.४१ करोड
१.४१ करोड
Other non operating income
-१४.९८ करोड
-१४.९८ करोड
१.५० हजार
१.५० हजार
EBT including unusual items
-१६.६५ करोड
-१६.६५ करोड
१.७९ करोड
१.७९ करोड
EBT excluding unusual items
-१६.७६ करोड
-१६.७६ करोड
१.६६ करोड
१.६६ करोड
Income tax expense
९.५० हजार
९.५० हजार
१.४० लाख
१.४० लाख
Effective tax rate
-०.०१%
-०.०१%
०.७८%
०.७८%
Other operating expenses
-
-
-
-
Net income
-१६.६६ करोड
-१६.६६ करोड
१.७८ करोड
१.७८ करोड
Net profit margin
-१,१५७.२८%
-१,१५७.२८%
३३.४३%
३३.४३%
Earnings per share
-
-
-
-
Interest and investment income
१२.९२ लाख
१२.९२ लाख
३८.९० लाख
३८.९० लाख
Interest expense
-५६.०० हजार
-५६.०० हजार
-८३.०० हजार
-८३.०० हजार
Net interest expenses
१२.३६ लाख
१२.३६ लाख
३८.०८ लाख
३८.०८ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-१.८१ करोड
-१.८१ करोड
१.४९ करोड
१.४९ करोड
Gain or loss from assets sale
६३.५० हजार
६३.५० हजार
-
-
AI content may include mistakes. Learn more
Google एपहरू